Department of Gynecologic Surgery, The Third Affiliated Teaching Hospital of Xinjiang Medical University (Affiliated Cancer Hospital), Xinjiang, Urumqi 830011, China.
Center of Heath Management, the First Affiliated Hospital of Xinjiang Medical University, Xinjiang, Urumqi 830011, China.
Chin Med J (Engl). 2023 May 5;136(9):1098-1110. doi: 10.1097/CM9.0000000000002201.
Ovarian cancer is one of the most widespread malignant diseases of the female reproductive system worldwide. The plurality of ovarian cancer is diagnosed with metastasis in the abdominal cavity. Epithelial-mesenchymal transition (EMT) exerts a vital role in tumor cell metastasis. However, it remains unclear whether long non-coding RNA (lncRNA) are implicated in EMT and influence ovarian cancer cell invasion and metastasis. This study was designed to investigate the impacts of lncRNA AC005224.4 on ovarian cancer.
LncRNA AC005224.4, miR-140-3p, and snail family transcriptional repressor 2 ( SNAI2 ) expression levels in ovarian cancer and normal ovarian tissues were determined using real-time quantitative polymerase chain reaction (qRT-PCR). Cell Counting Kit-8 (CCK-8) and Transwell (migration and invasion) assays were conducted to measure SKOV3 and CAOV-3 cell proliferation and metastasis. E-cadherin, N-cadherin, Snail, and Vimentin contents were detected using Western blot. Nude mouse xenograft assay was utilized to validate AC005224.4 effects in vivo . Dual-luciferase reporter gene assay confirmed the targeted relationship between miR-140-3p and AC005224.4 or SNAI2 .
AC005224.4 and SNAI2 upregulation and miR-140-3p downregulation were observed in ovarian cancer tissues and cells. Silencing of AC005224.4 observably moderated SKOV3 and CAOV-3 cell proliferation, migration, invasion, and EMT process in vitro and impaired the tumorigenesis in vivo . miR-140-3p was a target of AC005224.4 and its reduced expression level was mediated by AC005224.4. miR-140-3p mimics decreased the proliferation, migration, and invasion of ovarian cancer cells. SNAI2 was identified as a novel target of miR-140-3p and its expression level was promoted by either AC005224.4 overexpression or miR-140-3p knockdown. Overexpression of SNAI2 also facilitated ovarian cancer cell viability and metastasis.
AC005224.4 was confirmed as an oncogene via sponging miR-140-3p and promoted SNAI2 expression, contributing to better understanding of ovarian cancer pathogenesis and shedding light on exploiting the novel lncRNA-directed therapy against ovarian cancer.
卵巢癌是全球女性生殖系统中最常见的恶性肿瘤之一。多数卵巢癌在腹腔转移时被诊断出来。上皮-间充质转化(EMT)在肿瘤细胞转移中起着重要作用。然而,长链非编码 RNA(lncRNA)是否参与 EMT 并影响卵巢癌细胞侵袭和转移尚不清楚。本研究旨在探讨 lncRNA AC005224.4 对卵巢癌的影响。
采用实时定量聚合酶链反应(qRT-PCR)检测卵巢癌和正常卵巢组织中 lncRNA AC005224.4、miR-140-3p 和 snail 家族转录阻遏物 2(SNAI2)的表达水平。用细胞计数试剂盒-8(CCK-8)和 Transwell(迁移和侵袭)实验检测 SKOV3 和 CAOV-3 细胞的增殖和转移。Western blot 检测 E-钙黏蛋白、N-钙黏蛋白、Snail 和波形蛋白含量。利用裸鼠异种移植实验验证 AC005224.4 在体内的作用。双荧光素酶报告基因实验证实了 miR-140-3p 与 AC005224.4 或 SNAI2 的靶向关系。
在卵巢癌组织和细胞中观察到 AC005224.4 和 SNAI2 的上调以及 miR-140-3p 的下调。沉默 AC005224.4 可显著调节 SKOV3 和 CAOV-3 细胞的体外增殖、迁移、侵袭和 EMT 过程,并抑制体内肿瘤发生。miR-140-3p 是 AC005224.4 的靶基因,其表达水平受 AC005224.4 调节。miR-140-3p 模拟物降低卵巢癌细胞的增殖、迁移和侵袭。SNAI2 被鉴定为 miR-140-3p 的一个新靶点,其表达水平受 AC005224.4 过表达或 miR-140-3p 下调的促进。SNAI2 的过表达也促进了卵巢癌细胞的活力和转移。
AC005224.4 通过海绵 miR-140-3p 被确认为一种癌基因,并促进 SNAI2 的表达,有助于更好地理解卵巢癌的发病机制,并为利用新型 lncRNA 靶向治疗卵巢癌提供了思路。